QPS检测方法检索器
经验证的检测方法
目前用于药代动力学、药效学和免疫原性的现代生物分析方法大部分基于LC-MS/MS和免疫分析方法。 但是,对于少量重要化合物,用这些技术进行生物分析不尽人意。 一个很好的替代方法是电感耦合等离子体质谱(ICP-MS)。 在ICP-MS中,样本被电感耦合等离子体离子化(离子化源),并使用质谱仪作为分离和检测目标离子的方法。
QPS检测列表含有多种经验证的检测方法,可满足您的全部分析需求。
QPS检测列表含有多种经验证的检测方法,可满足您的全部分析需求。
点击此处搜索检测方法!
17-Desacetyl Norgestimate (Norelgestromin)
| Matrix: | Human Plasma |
| Assay Range: | 0.02 - 10 ng/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Birth Control |
| Classification: | Drugs |
17α-Ethynylestradiol
Levonorgestrel
| Matrix: | Human Plasma |
| Assay Range: | 5.00 - 500 pg/mL 200 - 20,000 pg/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Birth Control |
| Classification: | Drugs |
19-Norandrosterone
19-Norethiocholanolone
| Matrix: | Human Plasma |
| Assay Range: | 20 - 5,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Drugs |
4-Phenylbutyric acid
| Matrix: | Human Plasma |
| Assay Range: | 0.2 - 200 µg/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drugs |
5-Fluorouracil (5-FU)
| Matrix: | Human Plasma |
| Assay Range: | 5 - 3,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drugs |
6-Methoxy-2-Naphthylacetic acid (Nebumetane)
| Matrix: | Human Plasma |
| Assay Range: | 0.5 - 75 µg/ml |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | HPLC-UV |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drugs |
Abacavir
Dolutegravir
Lamivudine
| Matrix: | Human Plasma |
| Assay Range: | 4 - 2200 ng/mL 3 - 1650 ng/mL 2 - 1100 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiviral - HIV |
| Classification: | Drugs |
Abacavir (ABC)
Lamivudine (3TC)
| Matrix: | Human Plasma |
| Assay Range: | 20 - 12,000 ng/mL 15 - 6,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiviral - HIV |
| Classification: | Drugs |
Abacavir (ABC)
| Matrix: | Human Plasma |
| Assay Range: | 20 - 10,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiviral - HIV |
| Classification: | Drugs |
Abacavir (ABC)
| Matrix: | Human Plasma |
| Assay Range: | 5 - 5,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antiviral - HIV |
| Classification: | Drugs |
Abeta (Aß) Total
| Matrix: | Human Plasma |
| Assay Range: | 100 - 8,000 pg/mL |
| Sample Volume: | 0.025 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | ECL (MSD) |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Alzheimer's Disease |
| Classification: | Biomarkers |
Abeta (Aß) Total
| Matrix: | Human CSF |
| Assay Range: | 200 - 10,000 pg/mL |
| Sample Volume: | 0.025 mL |
| Anti-Coagulant: | N/A |
| Storage Temperature (°C): | -70 |
| Platform: | ECL (MSD) |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Alzheimer's Disease |
| Classification: | Biomarkers |
Abiraterone
| Matrix: | Human Plasma |
| Assay Range: | 0.2 - 500 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Fluoride Oxalate |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drugs |
Abiraterone
| Matrix: | Human Plasma |
| Assay Range: | 0.2 - 250 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drugs |
Abiraterone
| Matrix: | Human Plasma |
| Assay Range: | 1 - 1,000 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drugs |
Acetaminophen
Dextromethorphan
Dextrorphan
| Matrix: | Dog Plasma |
| Assay Range: | 1 - 500 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drugs |
Acetaminophen
Dextromethorphan
Dextrorphan
| Matrix: | Rat Plasma |
| Assay Range: | 10 - 5,000 ng/mL 1 - 500 ng/mL 1 - 500 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Respiratory |
| Classification: | Drugs |
Acetaminophen
Propoxyphene
| Matrix: | Human Plasma |
| Assay Range: | 50 - 2,000 ng/mL 1 - 400 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drugs |
Acetaminophen
| Matrix: | Human Plasma |
| Assay Range: | 50 - 30,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drugs |
Acetaminophen
| Matrix: | Human Plasma |
| Assay Range: | 75 - 20,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drugs |
Acetazolamide
| Matrix: | Human Plasma |
| Assay Range: | 50 - 30,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiseizure |
| Classification: | Drugs |
Acetazolamide
| Matrix: | Human Plasma |
| Assay Range: | 0.1 - 50 µg/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiseizure |
| Classification: | Drugs |
Acetylsalicyclic acid
Dipyridamole
Salicyclic Acid
| Matrix: | Human Plasma |
| Assay Range: | 2 - 500 ng/mL 20 - 4,000 ng/mL 40 - 4,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drugs |
Acetylsalicylic Acid
Salicylic Acid
| Matrix: | Human Plasma |
| Assay Range: | 10 - 2,500 ng/mL 50 - 10,000 ng/mL |
| Sample Volume: | 0.4 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drugs |
Acetylsalicylic Acid
Salicylic Acid
| Matrix: | Human Plasma |
| Assay Range: | 50 - 2,500 ng/mL 500 - 7,000 ng/mL |
| Sample Volume: | 0.25 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drugs |